Author(s) |
(Date) |
Paper Title |
Citation |
Model Type |
Applications |
Full Text |
| Kubota S, et al. Mouse over for full list Kubota S, Tokunaga K, Umezu T, Yokomizo-Nakano T, Sun Y, Oshima M, Tan KT, Yang H, Kanai A, Iwanaga E, Asou N, Maeda T, Nakagata N, Iwama A, Ohyashiki K, Osato M, Sashida G |
(2019) | Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm. | Nat Commun 10(1):1653 | Oncology | ||
| Jost Seibler, et al. Mouse over for full list Jost Seibler, Branko Zevnik, Birgit Küter-Luks, Susanne Andreas, Heidrun Kern, Thomas Hennek, Anja Rode, Cornelia Heimann, Nicole Faust, Gunther Kauselmann, Michael Schoor, Rudolf Jaenisch, Klaus Rajewsky, Ralf Kühn, and Frieder Schwenk |
(2003) | Rapid generation of inducible mouse mutants | Nucleic Acids Res. 2003 Feb 15; 31(4): e12 | |||
| Waisman A, et al. Mouse over for full list Waisman A, Kraus M, Seagal J, Ghosh S, Melamed D, Song J, Sasaki Y, Classen S, Lutz C, Brombacher F, Nitschke L, Rajewsky K |
(2007) | IgG1 B cell receptor signaling is inhibited by CD22 and promotes the development of B cells whose survival is less dependent on Ig alpha/beta. | J. Exp. Med. 204(4):747-58 | T And/Or B Cell Function |
Welcome! Tell us a little about yourself